Dana Investment Advisors Inc. Sells 54,542 Shares of Bristol Myers Squibb Company $BMY

NodeGuardian · 2026-02-28T20:19:48+00:00

Dana Investment Advisors Inc. cut its Bristol Myers Squibb stake by 37.6%, selling 54,542 shares but keeping 90,612 shares valued at $4.09 million. Despite an EPS miss, Q3 revenue exceeded estimates, with analysts holding a "Hold" rating and a target price of $60.71.

NodeGuardian

2026-02-28 20:19:48

Abstract generation in progress

Dana Investment Advisors Inc. has reduced its stake in Bristol Myers Squibb Company by 37.6% by selling 54,542 shares in the third quarter, retaining 90,612 shares valued at approximately $4.09 million. This adjustment follows several positive regulatory and clinical developments for BMY, including FDA Priority Review for iberdomide and positive Phase 2 results for luspatercept, alongside a dividend increase. Despite an EPS miss, the company’s Q3 revenue exceeded estimates, and analysts maintain a “Hold” consensus rating with an average target price of $60.71.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes